DOI: https://doi.org/10.22263/2312-4156.2019.1.30
Dikareva E.A.
The effect of Helicobacter pylori eradication on the morphological state of the gastric mucosa in patients with rheumatoid arthritis who have been taking nonsteroidal anti-inflammatory drugs for a long time
Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2019;18(1):30-38.
Abstract.
Objectives. To make a prospective evaluation of the effect of Helicobacter pylori (H. pylori) eradication on the gastric mucosa (GM) in patients with rheumatoid arthritis (RA) who have been taking nonsteroidal anti-inflammatory drugs (NSAIDs) for a long time.
Material and methods. The study included 116 patients with RA and with H. pylori infection, who took NSAIDs for a long time. Two groups were formed by means of randomization: a group of patients who underwent H. pylori eradication (57 persons); and a comparison group (59 subjects), in which eradication therapy was not used. The follow-up examination to identify endoscopic signs of gastropathy induced the intake of NSAIDs (NSAID-gastropathy) after the provided treatment was conducted in 45 patients who received eradication therapy and in 16 patients from the comparison group in 0,50 (0,25; 0,91) a year.
Results. The frequency of successful H. pylori eradication in patients with RA who had been taking NSAIDs for a long time made up 82,2%. Patients with successful H. pylori eradication demonstrated a statistically significant decrease in the indices of activity (p<0,001), inflammation (p<0,001) and atrophy (р=0,017) in the GM of the antrum and that in the indices of activity (p<0,001) and inflammation (p<0,001) in the GM of the fundus of the stomach. In the comparison group, where eradication therapy hadn’t been provided, no statistically significant differences in the morphological parameters of the gastric mucosa were revealed.
Conclusions. Successful eradication of the H. pylori microorganism in patients with RA, who had been taking NSAIDs for a long time and continued to take them in the future, was accompanied by a positive dynamics of the GM morphological parameters.
Key words: rheumatoid arthritis, nonsteroidal anti-inflammatory drugs, eradication, Helicobacter pylori.
References
1. Kono Y, Okada H, Takenaka R, Miura K, Kanzaki H, Hori K, et al. Does Helicobacter pylori exacerbate gastric mucosal injury in users of nonsteroidal anti-inflammatory drugs? A multicenter, retrospective, case-control study. Gut Liver. 2016 Jan;10(1):69-75. doi: http://dx.doi.org/10.5009/gnl14372
2. Pimanov SI, Dikareva EA, Makarenko EV. How to reduce gastrointestinal risk when using non-steroidal anti-inflammatory drugs. Consilium Medicum. 2014;16(2):95-9. (In Russ.)
3. Pimanov SI, Semenova EV, Makarenko EV, Ruselik EA. Gastroduodenal ulcers caused by antiplatelet and non-steroidal anti-inflammatory drugs: prevention according to new recommendations. Consilium Medicum. 2009;11(8):13-20. (In Russ.)
4. Pimanov SI, Makarenko EV, Semenova EV, Koroleva YuI. Recommendations of international conciliation documents on prevention of stomach cancer and recurrence of gastroduodenal ulcer. Consilium Medicum. 2008;10(8):9-15. (In Russ.)
5. Dikareva EA, Voropaeva AV, Makarenko EV, Pimanov SI. The importance of Helicobacter pylori genes in the development of gastropathy induced by non-steroidal anti-inflammatory drugs. Problemy Zdorov'ia Ekologii. 2015;(2):37-41. (In Russ.)
6. Pimanov SI, Makarenko EV. Diagnostics and treatment of Helicobacter pylori infection: The Maastricht-V Florentine Consensus and commentary. Minsk, RB: Chetyre chetverti; 2017. 90 р. (In Russ.)
7. Brzozowski T, Konturek PC, Sliwowski Z, Kwiecień S, Drozdowicz D, Pawlik M, et al. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. J Physiol Pharmacol. 2006 Sep;57 Suppl 3:67-79.
8. Pimanov SI, Makarenko EV, Dikareva EA. Anti-secretory therapy: convincing benefits and potential risks. Med Sovet. 2018;(3):26-31. (In Russ.)
9. Pimanov SI, Makarenko EV, Ruselik EA. Pharmacotherapy for acid-dependent diseases: proven truths and new recommendations. Med Sovet. 2012;(3):22-8. (In Russ.)
10. Pimanov SI, Makarenko EV, Ruselik EA. Prevention of the adverse effects of non-steroidal anti-inflammatory drugs: rules of choice. Med Sovet. 2012;(9):68-71. (In Russ.)
11. Chi TY, Zhu HM, Zhang M. Risk factors associated with nonsteroidal anti-inflammatory drugs (NSAIDs)-induced gastrointestinal bleeding resulting on people over 60 years old in Beijing. Medicine (Baltimore). 2018 May;97(18):e0665. doi: http://dx.doi.org/10.1097/MD.0000000000010665
12. Dikareva EA, Makarenko EV, Pimanov SI. Risk assessment of gastropathy induced by non-steroidal anti-inflammatory drugs on the basis of international conciliation documents. Vestn VGMU. 2015;14(5):39-45. (In Russ.)
13. Dikareva EA, Makarenko EV, Pimanov SI. Prediction of the development of gastropathy induced by non-steroidal anti-inflammatory agents in patients with rheumatoid arthritis. Vestn VGMU. 2015;14(5):46-56. (In Russ.)
14. Dikareva EA. Influence of adherence to proton pump inhibitor treatment on the frequency of gastropathy induced by non-steroidal anti-inflammatory drugs. Vestn VGMU. 2015;14(1):41-7. (In Russ.)
15. Pimanov SI, Dikareva EA, Makarenko EV. Adherence to pharmacotherapy is a prerequisite for effective treatment. Lecheb Delo. 2014;(5):47-52. (In Russ.)
16. Pimanov SI, Makarenko EV, Dikareva EA. Compliance with proton pump inhibitor therapy with continuous use of non-steroidal anti-inflammatory agents. Terapevt Arkhiv. 2015;87(4):58-61. (In Russ.)
17. De Leest HT, Steen KS, Bloemena E, Lems WF, Kuipers EJ, Van de Laar MA, et al. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. J Clin Gastroenterol. 2009 Feb;43(2):140-6. doi: http://dx.doi.org/10.1097/MCG.0b013e3181595b40
18. Frezza M, Gorji N, Melato M. The histopathology of nonsteroidal anti–inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events. J Clin Pathol. 2001 Jul;54(7):521-5.
19. Dikareva EA, Matveenko ME, Pimanov SI, Makarenko EV. Clinical, endoscopic and morphological effects of Helicobacter pylori eradication in patients with long-term use of non-steroidal anti-inflammatory agents. Vestn VGMU. 2014;13(5):52-9. (In Russ.)
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315-24.
21. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996 Oct;20(10):1161-81.
22. Fichman S, Niv Y. Histological changes in the gastric mucosa after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1183-8.
23. Ito M, Haruma K, Kamada T, Mihara M, Kim S, Kitadai Y, et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther. 2002 Aug;16(8):1449-56.
24. Caselli M, LaCorte R, DeCarlo L, Aleotti A, Trevisani L, Ruina M, et al. Histological findings in gastric mucosa in patients treated with non-steroidal anti-inflammatory drugs. J Clin Pathol. 1995 Jun;48(6):553-5.
25. Quinn CM, Bjarnason I, Price AB. Gastritis in patients on non-steroidal anti-inflammatory drugs. Histopathology. 1993 Oct;23(4):341-8.
26. McCarthy DM. Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory drugs. Scand J Gastroenterol Suppl. 1991;187:91-7.
27. Voutilainen M, Sokka T, Juhola M, Farkkilä M, Hannonen P. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer. Scand J Gastroenterol. 1998 Aug;33(8):811-6.
Information about authors:
Dikareva E.A .– Candidate of Medical Sciences, associate professor of the General Practitioner Chair with the course of Outpatient Therapy, Vitebsk State Order of Peoples’ Friendship Medical University.
Correspondence address: Republic of Belarus, 210009, Vitebsk, 27 Frunze ave., Vitebsk State Order of Peoples’ Friendship Medical University, General Practitioner Chair with the course of Outpatient Therapy. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Elena A. Dikareva.
